
Sign up to save your podcasts
Or


In this episode, we explore the 340B Drug Pricing Program, an essential yet complex component of the American drug supply landscape that aims to enable healthcare entities to offer more affordable medication to underserved populations. We interview Antonio Ciaccia, a drug pricing and 340B expert who provides an in-depth look at how the program works, its financial incentives, and how stakeholders have exploited this well-intentioned program, all to the detriment of patients.
Medical terminology referenced in this episode:
Questions or comments?
Email us at [email protected].
Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.
By Mark Hansan and Dr. Scott Howell5
1919 ratings
In this episode, we explore the 340B Drug Pricing Program, an essential yet complex component of the American drug supply landscape that aims to enable healthcare entities to offer more affordable medication to underserved populations. We interview Antonio Ciaccia, a drug pricing and 340B expert who provides an in-depth look at how the program works, its financial incentives, and how stakeholders have exploited this well-intentioned program, all to the detriment of patients.
Medical terminology referenced in this episode:
Questions or comments?
Email us at [email protected].
Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.

32,090 Listeners

227,699 Listeners

43,567 Listeners

4,304 Listeners

87,143 Listeners

112,467 Listeners

499 Listeners

12,250 Listeners

190 Listeners

6,057 Listeners

5,467 Listeners

16,072 Listeners

482 Listeners

12,887 Listeners

75 Listeners